Van ECK Associates Corp Has $56 51 Million Position in Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price objective hoisted by TD Cowen from $1,020.00 to $1,030.00 in a report published on Wednesday morning, Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. A number of other analysts also recently commented on the stock. Truist Financial restated a buy rating […]
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by TD Cowen from $1,020.00 to $1,030.00 in a report published on Wednesday morning, Benzinga reports. TD Cowen currently has a buy rating on the biopharmaceutical company’s stock. Several other equities analysts have also recently weighed in on REGN. StockNews.com cut shares of Regeneron […]
Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) is Cutter & CO Brokerage Inc s 9th Largest Position theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
New York State Common Retirement Fund Has $131 92 Million Position in Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.